ArticlePloS one2026
High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFrontline healthcare workers (HCWs) are among the first professionals significantly impacted by epidemics and pandemics. During the COVID-19 pandemic, HCWs had an increased risk of infection. This study aimed to determine the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Nigerian HCWs.
methodsA cross-sectional study of 1,247 randomly selected HCWs, was conducted across seven healthcare facilities in Nigeria, from August 2022 through December 2022 (Epi week 31-51). This study had two parts: the knowledge, attitude, and practices (KAP) survey and the seroprevalence of SARS-CoV-2 antibodies. Healthcare cadres enrolled were nurses, laboratorians, doctors, and pharmacists who provided informed consent before enrollment. An antigen-based COVID-19 rapid diagnostic test was used to screen all HCWs at enrollment, and a SARS-CoV-2 Multi-Antigen IgG assay was used to test for the presence of SARS-CoV-2 antibodies for the seroprevalence component of the study.
findingsA total of 1,247 HCWs were enrolled 682 (54.6%) nurses, 286 (22.9%) laboratorians, 222(18.0%) doctors, and 57(4.5%) pharmacists. The majority HCWs were males (70.5%), lived in urban areas (90.2%), had tertiary education (64.0%), and were married (81.7%). The proportion of HCWs that used drugs or smoked was 0.2%. The seropositivity of SARS-CoV-2 amongst HCWs was 98.2% of which 80.6% where due to the Nucleocapsid protein and 17.6% due to the Spike protein. Nurses were three times more likely to be seropositive for COVID-19 than laboratorians (P < 0.05).
interpretationOur findings reveal a high prevalence of SARS-CoV-2 antibodies among HCWs, especially among nurses. At the time of this study, half of the HCWs were unvaccinated for COVID-19. As frontline HCWs remain at increased risk of occupational exposure, this study highlights the need to strengthen infection prevention strategies, particularly vaccination and infection prevention and control measures, to protect the healthcare workforce.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.